Literature DB >> 15251970

A new technology for mutation detection.

W Shackelford1, S Deng, K Murayama, J Wang.   

Abstract

A sensitive, accurate, and simple method, called shifted termination assay (STA), was developed for detection of genetic mutations. The STA technology can be used to detect genetic mutations in polymerase chain reaction (PCR)-amplified samples of tissue, and plasma and serum that include circulating DNA containing point mutations, insertions, deletions, translocations, or single nucleotide polymorphisms (SNPs). STA is a multiple-base and multiple-cycle primer extension based detection method that can identify mutant DNA in samples containing as little as 1% mutant DNA in a mixture with 99% wild-type DNA. On the basis of the STA method, a mutation detection kit, called Mutector, was developed. Mutector is a 96-well microplate format test kit with colorimetric or luminescent detection options. An initial study shows that Mutector is more accurate and sensitive than sequencing and PCR restriction enzyme analysis methods in detecting DNA mutations from clinical samples.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251970     DOI: 10.1196/annals.1318.040

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studies.

Authors:  Semir Vranic; Zoran Gatalica; Zhao-Yi Wang
Journal:  Oncol Lett       Date:  2011-11       Impact factor: 2.967

2.  BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.

Authors:  Carol Li; Kathleen C Lee; Eric B Schneider; Martha A Zeiger
Journal:  J Clin Endocrinol Metab       Date:  2012-10-09       Impact factor: 5.958

3.  Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer?

Authors:  Kathleen C Lee; Carol Li; Eric B Schneider; Yongchun Wang; Helina Somervell; Matthew Krafft; Christopher B Umbricht; Martha A Zeiger
Journal:  Surgery       Date:  2012-10-11       Impact factor: 3.982

4.  Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies.

Authors:  Matthew S Lalonde; Ryan M Troyer; Aslam R Syed; Stanley Bulime; Korey Demers; Francis Bajunirwe; Eric J Arts
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

5.  Novel KRAS gene mutations in sporadic colorectal cancer.

Authors:  Walid M Naser; Mohamed A Shawarby; Dalal M Al-Tamimi; Arun Seth; Abdulaziz Al-Quorain; Areej M Al Nemer; Omar M E Albagha
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.